If you bought
shares of Immunovant Inc (IMVT) on
shares of Immunovant Inc (IMVT) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12
Immunovant, Inc., formerly Health Sciences Acquisitions Corp, is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for patients with autoimmune diseases. It is developing IMVT-1401, a human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies. IMVT-1401 is being developed to target the neonatal Fc receptor (FcRn).
Address: 320 West 37Th Street New York City NEW YORK 10018